Unit 1: Nature of Drug Flashcards
the science of drug preparation & the
medical uses of drugs
Materia medica
Receptors for which no ligand has been discovered & function can only be guessed
orphan receptors
short nucleotide chains that can interfere with the readout of genes & the transcription of RNA
Antisense Oligonucleotides (ANOs)
Body of knowledge concerned with the action of chemicals on biologic systems, especially by binding to regulatory molecules (receptors) and activating or inhibiting normal body processes
pharmacology
Area of pharmacology concerned with the use of chemicals in the prevention, diagnosis, and treatment of disease, especially in humans
medical pharmacology
Area of pharmacology concerned with the undesirable effects of chemicals on biologic systems
toxicology
Relation of the individual’s genetic makeup to his or her response to specific drugs (brought about by the exploration of the human gene)
pharmacogenomics
Any substance that brings about a change in biologic function through chemical actions
drug
Specific molecule in the biologic system that plays a regulatory role
receptor
Explains what the body will do with the drug (how the drug is handled by the patient)
pharmacokinetics
4 basic concepts of pharmacokinetics
absorption
distribution
metabolism
elimination
Explains what the drug does to the body
pharmacodynamics
Involves the follwing concepts: receptor, receptor sites, and inert binding sites
pharmacodynamics
T/F:
Drugs can produce effects in the body with or without binding sites.
false
Receptors (binding sites) are always required; no binding site = no effect in the body
T/F:
Drugs are made of chemical components similar to the human body: inorganic ions, nonpeptide organic molecules, small peptides and proteins, nucleic acids, lipids, and carbohydrates.
true
molecules or substances found in plants or animals, where many are partially or completely synthetic
hormones
xenobiotics (foreign substances that enter the body)
3 physical natures of drugs
solid (tablets, granules)
liquid (syrup, suspension)
gas (aerosolized anesthetics)
Drugs are given:
a. directly at the intended site of action
b. at a site distant from the intended site of action
b. at a site distant from the intended site of action
(ex. For headache, you consume an analgesic (pain reliever) instead of patching it to your head.)
Most drugs have MW between _____ and _____.
100
1000
MW for selective binding
100 MW
(Small drugs require small receptors therefore it could only accept or adapt certain size of molecules)
MW for traversing to different barriers of the body
1000 MW
MW where drugs cannot move within the body and are given at the site of action
> 1000 MW
T/F:
The shape of the drug affects the duration of the action as well as the potency of a drug.
true
chemical forces or bonds through which the drug interacts with the receptors
drug receptor bonds
__________ bonds are more selective bonds
a. stronger
b. weaker
b. weaker
Arrange the types of bonds from strongest to weakest:
electrostatic
hydrophobic
covalent
covalent > electrostatic > hydrophobic
strongest bond that is irreversible
covalent bond
type of bond that is more common but is weaker (e.g. bond between cation and an anion)
electrostatic
weakest bond seen in highly soluble drugs
hydrophobic bonds
Give the pharmacodynamic sequence where the receptor makes the effects (no effector molecule)
Drug (D) + receptor-effector (R) → drug-receptor-effector complex → effect
Give the pharmacodynamic sequence where the drug receptor complex produces an intracellular effector, and it is this intracellular effector that mediates an action of the drug
D + R → drug-receptor complex → effector molecule → effect
Give the pharmacodynamic sequence where the drug receptor complex activates a coupling molecule or enzyme inside
D + R → D-R complex → activation of coupling molecule → effector molecule → effect
Inhibition of metabolism of endogenous activator → _________ (increased, decreased) activator action on an effector molecule → increased effect
increased
T/F:
Some of the receptor pool must exist in Ra (active) form, and this can occur in the absence of the agonist.
true
(constitutive activity; may produce same physiologic effect as agonist-induced activity)
Antagonist action can be overcome by increasing the dosage of ________.
agonist
binds to and activate the receptor
agonist
Activates receptor-effector system to the maximum extent (Ra-D pool) {activated form}
full agonist
Binds to the same receptors and activate them in the same way but do not evoke as great a response
partial agonist
Binds to a site on the receptor molecule separate from the agonist binding site
allosteric modulators
T/F:
Allosteric modulators modifies receptor activity by blocking agonist activity
false
(does not block agonist activity, binds to another site)
T/F:
Allosteric modulators are noncompetitive and may increase or decrease response to agonist
true
Drug has a stronger affinity for the Ri pool (nonfunctional form)
inverse agonist
Inverse agonist ___________ constitutive activity
a. increases
b. decreases
decreases
T/F:
Inverse agonist results in effects that are almost the same with the effects
produced by conventional agonists
false
opposite effects
Several other binding sites in the
receptors and for other chemicals that bind to the receptors
allosteric site
binds to a receptor, competes with and prevent binding by other molecules
antagonist (competitive inhibitor)
inactive precursor that must be administered and converted to the active drug by biologic process inside the body
prodrug
Movement of drug molecules into and within the biologic environment
permeation
type of permeation:
for water-soluble drugs
Aqueous Diffusion
type of permeation for membranes of capillaries with small water-filled pores
Aqueous Diffusion
Aqueous Diffusion
a. active process, governed by Fick’s law
b. active process, not governed by Fick’s law
c. passive process, governed by Fick’s law
d. passive process, not governed by Fick’s law
c. passive process, governed by Fick’s law
equation for Fick’s Law of Diffusion
Flux (moles/ unit time) = C1 - C2 * (Permeability coefficient / thickness) * area
type of permeation:
movement of molecules through membranes and other lipid structures
lipid diffusion
type of permeation:
Most important factor for drug permeation
lipid diffusion